NCT00460486View on ClinicalTrials.gov

Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization Schedule

PHASE3CompletedINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

November 30, 2007

Conditions
Encephalitis, Tick-Borne
Interventions
BIOLOGICAL

Formaldehyde inactivated, sucrose gradient purified TBE virus antigen, strain Neudörfl

Trial Locations (4)

30-969

Centrum Badan Farmakologii Klinicznej monipol, Krakow

10-117

"Niepubliczny ZOZ Atarax s.c.", Olsztyn

10-295

"Niepubliczny ZOZ VITA", Olsztyn

10-461

"PANTAMED Sp. z o.o.", Olsztyn

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00460486 - Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization Schedule | Biotech Hunter | Biotech Hunter